BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260726
DTEND;VALUE=DATE:20260731
DTSTAMP:20260501T114859Z
CREATED:20260501T114859Z
LAST-MODIFIED:20260501T114859Z
UID:10318-1785024000-1785455999@thebiocalendar.com
SUMMARY:ADLM Annual Meeting
DESCRIPTION:July 26-30\, 2026 \nAnaheim Convention Center\nAnaheim\, CA\, USA \nSpeak your mind. Now accepting abstracts – inspire a global lab med community with your brilliance at #ADLM26. Accepted presenters will be part of a globally acclaimed scientific program. \nADLM 2026 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) is a program of the Association for Diagnostics & Laboratory Medicine (ADLM). Great minds converge to discuss the latest science and prepare for what’s next in the field. Experience all this and more: \n\nConnect with global leaders in clinical chemistry\, molecular diagnostics\, mass spectrometry\, translational medicine\, lab management\, and other areas of breaking science in laboratory medicine.\nLearn about cutting edge technology at the ADLM Clinical Lab Expo featuring 750+ exhibitors and 200+ new products/services.\nHear vital research and learn about important changes in the field. With more than 250 educational opportunities in the form of lectures\, plenary sessions\, scientific sessions\, and roundtable sessions\, you can design an educational experience that meets your need to stay ahead of changes in the field.\n\nStart planning today. Save when you register early — registration is now open!
URL:https://thebiocalendar.com/event/adlm-annual-meeting/
LOCATION:Anaheim\, Anaheim\, CA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260728T110000
DTEND;TZID=America/Los_Angeles:20260728T120000
DTSTAMP:20260714T200041Z
CREATED:20260701T172846Z
LAST-MODIFIED:20260714T200041Z
UID:10717-1785236400-1785240000@thebiocalendar.com
SUMMARY:Rewriting the Code: Advances and Challenges in Pediatric Gene Therapy
DESCRIPTION:Pediatric gene therapy is rapidly reshaping what is possible for children born with rare genetic diseases. Join Dr. Rachel Abu Taleb\, Medical Director\, Medical Affairs at Veristat\, for a look at the platforms driving clinical progress\, including AAV vectors\, lentiviral approaches\, and CRISPR-based gene editing. \nThrough examples such as Luxturna\, Zolgensma\, Casgevy\, and Lyfgenia\, this webinar will explore what recent approvals have taught the field across retinal\, neuromuscular\, and hematologic diseases. Dr. Abu Taleb will also discuss the safety\, regulatory\, long-term follow-up\, newborn screening\, and access challenges that continue to shape pediatric gene therapy development and delivery.
URL:https://thebiocalendar.com/event/rewriting-the-code-advances-and-challenges-in-pediatric-gene-therapy/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/07-28-26-Veristat-eBlast-700x200-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260731
DTSTAMP:20260630T200330Z
CREATED:20260630T200330Z
LAST-MODIFIED:20260630T200330Z
UID:10705-1785283200-1785455999@thebiocalendar.com
SUMMARY:Women Leaders in Life Sciences Law
DESCRIPTION:Benefit from Exceptional Opportunities for Professional Development\, Substantive Legal Discussion\, and Valuable Networking \nACI’s Summit for Women Leaders in Life Sciences Law is dedicated to providing the invaluable opportunities for networking and collaboration with the chance to meet\, engage with and learn from over 300 attorneys and executives from the biotech\, pharmaceutical\, and medical device industries and keep you up-to-date on the latest developments and challenges in the industry.
URL:https://thebiocalendar.com/event/women-leaders-in-life-sciences-law/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260729T110000
DTEND;TZID=America/Los_Angeles:20260729T120000
DTSTAMP:20260630T200707Z
CREATED:20260626T155658Z
LAST-MODIFIED:20260630T200707Z
UID:10653-1785322800-1785326400@thebiocalendar.com
SUMMARY:Building Inspection-Ready Systems with Digital Documentation
DESCRIPTION:This expert panel will discuss how digital documentation is reshaping inspection readiness. Panelists will explore the role of electronic batch records\, integrated quality systems\, and automated workflows in supporting compliance with ALCOA+ principles\, while enabling real-time visibility and faster audit response.
URL:https://thebiocalendar.com/event/building-inspection-ready-systems-with-digital-documentation/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/26_07-POL-Internal-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260729T110000
DTEND;TZID=America/Los_Angeles:20260729T120000
DTSTAMP:20260630T200643Z
CREATED:20260630T142341Z
LAST-MODIFIED:20260630T200643Z
UID:10688-1785322800-1785326400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update July 2026: Fill/Finish
DESCRIPTION:Looking for fill-finish manufacturing capacity? This webinar brings together leading CDMOs to showcase their latest sterile filling\, lyophilization\, and advanced packaging capabilities\, along with current facility availability and timelines. \nGain valuable insights into quality\, regulatory compliance\, and manufacturing options to help identify the right partner for your biopharmaceutical development and commercialization needs.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-july-2026-fill-finish/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/Outsourced-Pharma-Capabilities-Update-July-2026-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260729T130000
DTEND;TZID=America/Los_Angeles:20260729T140000
DTSTAMP:20260630T200627Z
CREATED:20260630T142856Z
LAST-MODIFIED:20260630T200627Z
UID:10693-1785330000-1785333600@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update July 2026: Large Molecule
DESCRIPTION:Explore the latest large molecule manufacturing capabilities from leading CDMOs in this informative webinar. \nLearn about advances in cell line development\, fermentation\, purification\, process optimization\, and scale-up\, while gaining insight into available capacity\, facility locations\, and timelines. \nWhether you’re evaluating manufacturing partners or planning future biologics production\, this session offers a practical overview to help you identify the right CDMO for your program.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-july-2026-large-molecule/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/Outsourced-Pharma-Capabilities-Update-July-2026-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260730T110000
DTEND;TZID=America/Los_Angeles:20260730T120000
DTSTAMP:20260630T200611Z
CREATED:20260629T174444Z
LAST-MODIFIED:20260630T200611Z
UID:10673-1785409200-1785412800@thebiocalendar.com
SUMMARY:Breaking the Bottleneck: How Modular Workflows Are Redefining CAR T Manufacturing Performance\, Flexibility\, and Scalability
DESCRIPTION:As cell therapies advance toward commercial-scale manufacturing\, developers can face increasing pressure to balance performance\, scalability\, and process flexibility. Flexible modular workflows are emerging as a powerful approach for scalable cell therapy manufacturing\, enabling enhanced process control\, workflow adaptability\, and operational efficiency while maintaining consistency across the manufacturing pipeline. These advantages can be particularly valuable in environments where evolving process requirements may challenge more fixed manufacturing approaches. \nIn this webinar\, we will explore how modular Gibco™ CTS™ workflows compare to an integrated system across critical CAR T manufacturing quality attributes\, including transduction efficiency\, T cell activation\, expansion\, and phenotype preservation. Data demonstrate that modular workflows can achieve high transduction efficiency (up to ~80% by day 8)\, increased CAR+ T cell yields\, and enhanced enrichment of stem cell–like memory (TSCM) populations\, which can be key factors associated with improved therapeutic potential. \nWe will also highlight how flexibility in workflow design enables parallel processing\, reduced instrument lock times\, and improved operational efficiency\, without compromising cell quality metrics such as purity and isolation efficiency. Attendees will gain practical insights into how modular strategies can future-proof manufacturing processes and support both early development and commercial-scale production. \nKey Learning Objectives \nUnderstand how modular workflows impact critical CAR T manufacturing attributes\, including transduction efficiency\, expansion\, and T cell phenotype\nEvaluate the trade-offs between integrated and modular systems in terms of scalability\, flexibility\, and operational efficiency\nLearn how flexible workflow design can enable parallel processing\, reduce bottlenecks\, and support evolving process requirements
URL:https://thebiocalendar.com/event/breaking-the-bottleneck-how-modular-workflows-are-redefining-car-t-manufacturing-performance-flexibility-and-scalability/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-30-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260804T110000
DTEND;TZID=America/Los_Angeles:20260804T120000
DTSTAMP:20260714T195429Z
CREATED:20260708T142914Z
LAST-MODIFIED:20260714T195429Z
UID:10744-1785841200-1785844800@thebiocalendar.com
SUMMARY:Ensuring Successful Technology Transfer In ADC Development
DESCRIPTION:Technology transfers can introduce risk and create knowledge gaps at every stage of development\, whether it’s moving a process from development to manufacturing\, transferring methods between analytical labs\, or onboarding a new CDMO partner. This is especially true in the development of antibody-drug conjugates (ADC)\, where the complexity of conjugation processes\, analytical characterization\, and specialized manufacturing expertise is often distributed across multiple CDMO partners. \nJoin Bioprocess Online’s Tyler Menichiello for an interactive panel discussion with Sourav Kundu\, Ph.D.\, senior vice president of development and manufacturing at NextCure\, and Will Olughu\, Ph.D.\, global CMC lead and senior principal scientist at Ipsen\, as they explore practical ways to navigate the transfer of process and analytical knowledge in ADC development to reduce risk and avoid delays.
URL:https://thebiocalendar.com/event/ensuring-successful-technology-transfer-in-adc-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/26_08-BPOL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260804T110000
DTEND;TZID=America/Los_Angeles:20260804T120000
DTSTAMP:20260714T195401Z
CREATED:20260714T151822Z
LAST-MODIFIED:20260714T195401Z
UID:10780-1785841200-1785844800@thebiocalendar.com
SUMMARY:Charting a Direct Pathway from Academia To CDMOs
DESCRIPTION:Moving promising research from the university lab to the CDMO suite requires more than breakthrough science—it requires the right documentation\, development strategy\, and manufacturing readiness. \nIn this Outsourced Pharma Live discussion\, industry experts explore how academic innovators and CDMOs can better align earlier\, build stronger technical packages\, and create a smoother path to outsourced development and manufacturing. \nWatch the discussion to learn how to make academic programs more CDMO-ready and accelerate the journey from discovery to execution.
URL:https://thebiocalendar.com/event/charting-a-direct-pathway-from-academia-to-cdmos/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-21.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260805T110000
DTEND;TZID=America/Los_Angeles:20260805T120000
DTSTAMP:20260714T195443Z
CREATED:20260714T152304Z
LAST-MODIFIED:20260714T195443Z
UID:10785-1785927600-1785931200@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update: Cell Line Development
DESCRIPTION:In this virtual event\, leading CDMOs will share how host selection\, vector design\, and clone screening strategies influence manufacturability from early development through commercialization. \nJoin us to learn what to evaluate early\, how to reduce downstream risk\, and how to make more informed cell line development decisions.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-cell-line-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-22.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260806T110000
DTEND;TZID=America/Los_Angeles:20260806T120000
DTSTAMP:20260714T195510Z
CREATED:20260708T142705Z
LAST-MODIFIED:20260714T195510Z
UID:10739-1786014000-1786017600@thebiocalendar.com
SUMMARY:Built for Growth: Engineering Flexible and Scalable Bioprocessing Strategies
DESCRIPTION:As biopharmaceutical manufacturing becomes increasingly global\, organizations face growing challenges in balancing flexibility\, standardization\, and scalability. CDMOs must accommodate sponsor-specific requirements\, manufacturers must transfer processes across geographically dispersed facilities\, and growing programs require equipment platforms that can scale without introducing unnecessary risk or complexity. \nSuccessfully navigating these challenges requires more than equipment; it requires a partner who can help define standards\, align stakeholders\, and anticipate future needs before they become obstacles. \nIn this webinar\, we will explore how a collaborative\, engineering-first approach can help biopharmaceutical manufacturers build more resilient and adaptable manufacturing strategies. Through real-world examples\, attendees will learn how organizations have addressed sponsor-driven variability in single-use filtration\, established global design standards across multiple manufacturing sites\, and developed scalable platform strategies that support seamless progression from clinical to commercial manufacturing. \nJoin us to discover how thoughtful system design\, strategic planning\, and trusted partnerships can help future-proof manufacturing operations while reducing risk\, simplifying technology transfer\, and supporting long-term growth. \nKey Objectives:\n~ Identify key strategies for balancing flexibility\, standardization\, and scalability in modern biopharmaceutical manufacturing\n~ Understand how collaborative engineering and trusted partnerships can simplify technology transfer\, align stakeholders\, and reduce operational risk\n~ Explore real-world approaches to designing manufacturing platforms that support sponsor variability today while enabling seamless growth from clinical to commercial production
URL:https://thebiocalendar.com/event/built-for-growth-engineering-flexible-and-scalable-bioprocessing-strategies/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-06-26-Asahi-Kasei-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260810
DTEND;VALUE=DATE:20260814
DTSTAMP:20260516T074742Z
CREATED:20260316T091025Z
LAST-MODIFIED:20260516T074742Z
UID:10023-1786320000-1786665599@thebiocalendar.com
SUMMARY:The Bioprocessing Summit 2026
DESCRIPTION:Elevate your expertise\, embrace innovation\, and join the global leaders who are transforming the future of bioprocessing. \nNow in its 18th year\, the Bioprocessing Summit unites a global community of scientists\, engineers\, and executives driving innovation and digitalization across process development\, scale-up\, quality\, and analytics for biologics\, antibodies\, cell and gene\, RNA\, and oligonucleotide therapies. \nExplore how technology\, data\, and AI are reshaping every stage of the bioprocessing journey — Transforming Bioprocessing for the Digital Age
URL:https://thebiocalendar.com/event/the-bioprocessing-summit-2026/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Featured,Summit
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/03/bps-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260811T100000
DTEND;TZID=America/Los_Angeles:20260811T120000
DTSTAMP:20260630T200555Z
CREATED:20260629T131816Z
LAST-MODIFIED:20260630T200555Z
UID:10658-1786442400-1786449600@thebiocalendar.com
SUMMARY:Cell Therapy Solutions
DESCRIPTION:Cell & Gene Tech Expo offers a live virtual experience designed to empower industry professionals in sourcing best-fit solutions for their cell and gene therapy manufacturing needs. Through this series of digital sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the cell and gene therapy manufacturing process. This interactive online experience ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Cell Therapy Solutions session will have the chance to explore the newest equipment and solutions offered by our presenting suppliers. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if suppliers can meet your needs – all from the convenience of your computer!
URL:https://thebiocalendar.com/event/cell-therapy-solutions/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/08-2026-CGTE-1280x720-CELL-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260812T100000
DTEND;TZID=America/Los_Angeles:20260812T120000
DTSTAMP:20260630T200536Z
CREATED:20260629T132028Z
LAST-MODIFIED:20260630T200536Z
UID:10663-1786528800-1786536000@thebiocalendar.com
SUMMARY:Gene Therapy Solutions
DESCRIPTION:Cell & Gene Tech Expo offers a live virtual experience designed to empower industry professionals in sourcing best-fit solutions for their cell and gene therapy manufacturing needs. Through this series of digital sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the cell and gene therapy manufacturing process. This interactive online experience ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Cell Therapy Solutions session will have the chance to explore the newest equipment and solutions offered by our presenting suppliers. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if suppliers can meet your needs – all from the convenience of your computer!
URL:https://thebiocalendar.com/event/gene-therapy-solutions/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/08-2026-CGTE-1280x720-GENE-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260812T130000
DTEND;TZID=America/Los_Angeles:20260812T140000
DTSTAMP:20260714T195536Z
CREATED:20260708T123716Z
LAST-MODIFIED:20260714T195536Z
UID:10734-1786539600-1786543200@thebiocalendar.com
SUMMARY:IRB in Action: A Live Mock Board Review
DESCRIPTION:Join Univo IRB for a unique educational webinar that takes attendees inside the IRB decision-making process through a live mock board review. Using a fictional agenda item based on real clinical and ethical challenges\, experienced IRB members will evaluate key protocol considerations including risk-benefit assessment\, informed consent\, participant protections\, recruitment strategies\, and regulatory compliance. This session is designed to help sponsors\, CROs\, sites\, and clinical research professionals better understand how IRBs review protocols and make decisions that support ethical\, compliant research.
URL:https://thebiocalendar.com/event/irb-in-action-a-live-mock-board-review/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Untitled-design-66.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260812T160000
DTEND;TZID=America/Los_Angeles:20260812T183000
DTSTAMP:20260714T195615Z
CREATED:20260709T153903Z
LAST-MODIFIED:20260714T195615Z
UID:10763-1786550400-1786559400@thebiocalendar.com
SUMMARY:BVS and BioMed Realty's Biotech Community Event in SSF
DESCRIPTION:Join Us for the BVS and BioMed Realty Biotech Community Event! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThe vendor fair is held at The Forum\, in the same building as Amgen and next to Genentech\, right in the heart of the large pharma/biotechs in South San Francisco. \n✨ What to Expect: \nVendor Exhibit: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nAppetizers & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nWe welcome the entire Bay Area Biotech Community to join us for this exciting event! This is a wonderful chance for everyone to come together\, share insights\, and celebrate the vibrant biotech landscape in our region. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes. \n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-and-biomed-realtys-biotech-community-event-in-ssf-8/
LOCATION:South San Francisco\, CA\, CA\, 94080\, United States
CATEGORIES:Expo,Trade Show
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/07/Biomed-Event-Flyer-08-12-26-Flyer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T100000
DTEND;TZID=America/Los_Angeles:20260813T120000
DTSTAMP:20260630T200519Z
CREATED:20260629T132259Z
LAST-MODIFIED:20260630T200519Z
UID:10668-1786615200-1786622400@thebiocalendar.com
SUMMARY:Commercial Readiness Solutions
DESCRIPTION:The journey from a successful lab result to a reliable\, GMP-compliant product is rarely a straight line. It’s a transition filled with technical hurdles\, regulatory pressure\, and the constant challenge of scaling without compromise. \nWe created the Commercial Readiness Solutions session to help you navigate this transition. This virtual event is designed to be highly practical – moving past high-level theory to focus on the specific tools and partnerships needed to solve the real-world bottlenecks in your production lifecycle. \nJoin us to evaluate the solutions and technologies essential for a sustainable commercial platform\, including: \nGMP Execution & Inspection Readiness: Building the protocols and confidence to meet global regulatory standards.\nManufacturing Scale-up: Leveraging closed-system automation to reduce manual risk and variability.\nContamination Control: Implementing advanced strategies to ensure sterility and product safety at scale.\nQC & Release Testing: Optimizing testing strategies to accelerate the path from the facility to the patient.\nValidation & Data Integrity: Ensuring your process documentation is robust\, transparent\, and compliant.\nDigital Infrastructure: Integrating eQMS\, MES\, and LIMS for a seamless\, paperless manufacturing environment. \nPractical Insights\, Not Just Presentations. Through solution-focused sessions and real-world case studies\, this event will highlight the supplier capabilities and technologies that reduce risk and accelerate your timelines. Our goal is to show you how to strengthen your operational resilience – maintaining the highest quality standards without sacrificing the throughput you need to stay competitive. \nMove Forward with Confidence. Whether you are preparing for your next inspection\, refining your control strategy\, or building a repeatable platform for the global market\, we are here to connect you with the right expertise. Join us to find the tools and insights you need to move confidently from development to commercial success – bringing life-changing therapies to more patients\, faster.
URL:https://thebiocalendar.com/event/commercial-readiness-solutions/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/08-2026-CGTE-1280x720-COMMERCIAL-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T110000
DTEND;TZID=America/Los_Angeles:20260813T120000
DTSTAMP:20260725T055907Z
CREATED:20260721T175625Z
LAST-MODIFIED:20260725T055907Z
UID:10806-1786618800-1786622400@thebiocalendar.com
SUMMARY:When Unexpected Particles Threaten Your Biologic
DESCRIPTION:Unexpected particle findings can raise critical questions about product quality\, patient safety\, and regulatory compliance. \nJoin KBI Biopharma’s experts to learn how clinical in-use studies and advanced particle forensics can help identify particle sources\, assess risk\, and build regulator-ready evidence for confident decision-making. \nRegister now to discover practical strategies for accelerating investigations\, supporting development timelines\, and responding effectively when unexpected particles threaten your biologic.
URL:https://thebiocalendar.com/event/when-unexpected-particles-threaten-your-biologic/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-13-26-KBI-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T130000
DTEND;TZID=America/Los_Angeles:20260813T140000
DTSTAMP:20260714T195655Z
CREATED:20260714T125112Z
LAST-MODIFIED:20260714T195655Z
UID:10770-1786626000-1786629600@thebiocalendar.com
SUMMARY:From Data to Decisions: AI and Multi-Omics for Cell Culture Development
DESCRIPTION:As biologics developers work to improve productivity\, maintain product quality\, and accelerate development timelines\, traditional optimization approaches can sometimes reach a point of diminishing returns. While cell culture processes generate vast amounts of biological and process data\, extracting actionable insights from that information remains a significant challenge. \nIn this webinar\, Thermo Fisher Scientific specialists discuss how the integration of multi-omics data\, artificial intelligence (AI)\, and deep cell culture expertise can help uncover the biological mechanisms driving process performance. Learn how AI-enabled analytics can support more informed decision-making\, identify optimization opportunities\, and accelerate media and process development. \nIn this session\, you will learn about:\n~ The role of multi-omics in understanding cell culture performance\n~ How AI is helping uncover biological drivers of productivity and quality\n~ Emerging applications of predictive modeling in media and process development\n~ New approaches to turning complex biological data into actionable insights \nKey topics include:\n~ Case study: using AI and metabolomics to overcome optimization plateaus\n~ Multi-omics approaches in cell culture development\n~ AI-enabled data integration and pattern recognition\n~ Understanding productivity and product quality trade-offs\n~ From biological data to development decisions \nDiscover how AI and multi-omics are helping developers move beyond descriptive analytics toward more predictive\, mechanism-based approaches to cell culture optimization.
URL:https://thebiocalendar.com/event/from-data-to-decisions-ai-and-multi-omics-for-cell-culture-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-13-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260818
DTEND;VALUE=DATE:20260828
DTSTAMP:20260725T054714Z
CREATED:20260724T211527Z
LAST-MODIFIED:20260725T054714Z
UID:10856-1787011200-1787875199@thebiocalendar.com
SUMMARY:The Matrix One West Coast MedTech Forum
DESCRIPTION:The Matrix One West Coast MedTech Forum is a free series of expert roundtables\, educational sessions and networking events taking place across California from 18 to 27 August 2026. Designed for professionals throughout the MedTech and life sciences community\, the programme brings together regulatory affairs\, quality\, engineering\, product\, digital health and business leaders. \nAttendees will explore some of the most important issues shaping medical device development\, including practical applications of AI\, regulatory submissions\, design control\, audit readiness\, quality management\, cloud connectivity\, cybersecurity and compliant product development. Events will take place across San Francisco\, Palo Alto\, Redwood City\, Los Angeles\, Irvine and San Diego\, featuring insights from industry experts\, legal specialists\, former FDA professionals and local MedTech leaders\, alongside valuable opportunities to connect with peers.
URL:https://thebiocalendar.com/event/the-matrix-one-west-coast-medtech-forum/
LOCATION:California (multiple locations)\, CA\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T110000
DTEND;TZID=America/Los_Angeles:20260818T120000
DTSTAMP:20260714T195850Z
CREATED:20260714T125327Z
LAST-MODIFIED:20260714T195850Z
UID:10775-1787050800-1787054400@thebiocalendar.com
SUMMARY:The Future of Cell Culture Media Development: Predictive Modeling and AI
DESCRIPTION:As biologics developers work to improve productivity\, reduce development timelines\, and manage manufacturing costs\, traditional media optimization approaches can become increasingly resource intensive. Predictive modeling is emerging as a complementary approach that can help integrate biological knowledge\, process data\, and artificial intelligence (AI) to support more efficient media development. \nIn this webinar\, Thermo Fisher Scientific specialists discuss how predictive modeling and AI are being applied to cell culture media development. Learn how computational modeling can help identify promising formulation strategies\, focus experimental efforts\, and support more informed development decisions while maintaining the critical role of scientific expertise. \nIn this session\, you will learn about:\n~ The emerging role of predictive modeling in cell culture media development\n~ How AI can help support formulation optimization\n~ The value of integrating biological\, analytical\, and process data\n~ How predictive modeling and scientific expertise can work together to inform development decisions \nKey topics include:\n~ Challenges with traditional media optimization approaches\n~ AI-guided formulation design and in silico modeling\n~ Human expertise in predictive model development and validation\n~ Cross-functional collaboration in AI-enabled media development\n~ Predictive modeling in biologics development \nDiscover how predictive modeling and AI are helping shape the future of cell culture media development by supporting more informed\, data-driven approaches to media optimization.
URL:https://thebiocalendar.com/event/the-future-of-cell-culture-media-development-predictive-modeling-and-ai/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-18-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T110000
DTEND;TZID=America/Los_Angeles:20260818T120000
DTSTAMP:20260725T055842Z
CREATED:20260721T180321Z
LAST-MODIFIED:20260725T055842Z
UID:10811-1787050800-1787054400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update August 2026: Nanoparticles
DESCRIPTION:Nanoparticle programs can stall when early formulation choices fail to hold up through scale-up\, tech transfer\, and manufacturing. \nJoin leading CDMO experts on August 18 at 11:00 AM ET to learn how decisions around lipid or polymer selection\, particle engineering\, process design\, and manufacturability can impact downstream success. \nRegister now to gain practical insights that will help you evaluate CDMO approaches\, ask sharper formulation questions\, and reduce risk before nanoparticle challenges become costly development setbacks.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-august-2026-nanoparticles/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T130000
DTEND;TZID=America/Los_Angeles:20260818T140000
DTSTAMP:20260725T055605Z
CREATED:20260721T180509Z
LAST-MODIFIED:20260725T055605Z
UID:10816-1787058000-1787061600@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update August 2026: Oral Solid Dose Formulation
DESCRIPTION:Oral solid dose programs can run into costly scale-up challenges when early formulation and process decisions aren’t built for long-term manufacturability. \nJoin leading CDMO experts on August 18 at 1:00 PM ET to explore how excipient selection\, granulation strategy\, particle engineering\, and process design can impact tech transfer\, validation\, and commercial manufacturing. \nRegister now to gain practical insights for evaluating CDMO capabilities\, identifying scale-up risks earlier\, and making more informed partner selection decisions.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-august-2026-oral-solid-dose-formulation/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-26.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260725T055053Z
CREATED:20260717T115757Z
LAST-MODIFIED:20260725T055053Z
UID:10796-1787223600-1787227200@thebiocalendar.com
SUMMARY:FDA Engagement Strategies And Best Practices Amid Agency Changes
DESCRIPTION:How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies? \nShould companies adjust their agency communication strategies or ask new questions during meetings? Our deeply experienced panelists will discuss key changes at the FDA\, how companies can get the most out of agency interactions\, and strategies to lower risks and avoid regulatory surprises. \nRegister for free today and secure your spot for this important virtual event.
URL:https://thebiocalendar.com/event/fda-engagement-strategies-and-best-practices-amid-agency-changes/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/26_08-LSL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260725T055023Z
CREATED:20260724T110739Z
LAST-MODIFIED:20260725T055023Z
UID:10851-1787223600-1787227200@thebiocalendar.com
SUMMARY:CAR-T for Relapsed/Refractory AML: From Discovery to First-in-Human Active Phase 1 Evaluation
DESCRIPTION:Join Dr. Marco Davila to explore a novel anti-CD83 CAR-T design for relapsed/refractory AML that overcomes myelosuppression barriers. Register for the live session. \nDeveloping effective Chimeric Antigen Receptor (CAR) T-cell therapies for Acute Myeloid Leukemia (AML) remains one of the most formidable frontiers in cellular immunotherapy. Unlike lymphoid malignancies where lineage-specific targets like CD19 or BCMA offer a clear therapeutic window\, AML presents a severe biological bottleneck. The vast majority of well-characterized myeloid antigens (such as CD33 or CD123) are shared with healthy hematopoietic stem and progenitor cells (HSPCs). Consequently\, conventional CAR-T approaches frequently induce prolonged\, life-threatening myelosuppression and bone marrow aplasia severely limiting their clinical utility. This webinar by Dr. Marco Davila will explore a paradigm-shifting strategy developed at Roswell Park Comprehensive Cancer Center that addresses this exact barrier: a novel CAR-T design targeting the CD83 antigen. \nOur discussion will center on the unique biology of CD83\, a protein highly expressed on malignant AML blasts but distinctively regulated in healthy tissues\, offering a pathway to selectively suppress leukemia cells while sparing critical progenitor stem cells. Moving from bench to bedside\, we will detail the rigorous process development and GMP manufacturing frameworks involved in generating this CAR-T cell therapy to be tested in clinic. Finally\, we will share insights into the initiation and objectives of the first-of-its-kind\, active Phase 1 clinical trial evaluating autologous anti-CD83 CAR-T cell infusions in patients with relapsed or refractory AML. Join us to discover how this dual-action architecture reshapes safety\, efficacy\, and translation benchmarks in the myeloid cell therapy space.
URL:https://thebiocalendar.com/event/car-t-for-relapsed-refractory-aml-from-discovery-to-first-in-human-active-phase-1-evaluation/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Miltenyi-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T133000
DTSTAMP:20260725T054955Z
CREATED:20260721T181456Z
LAST-MODIFIED:20260725T054955Z
UID:10823-1787223600-1787232600@thebiocalendar.com
SUMMARY:BVS’ Biotech Community Event at One Alexandria Square\, San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event in the Tribute Garden at One Alexandria Square. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Lunch & Drinks: Enjoy a delicious lunch as you network and explore the vendor exhibits. \nWe are inviting all the tenants and all local life science researchers and entrepreneurs in the surrounding area to attend. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-one-alexandria-square-san-diego/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Trade Show
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/07/BVS-Biotech-Event-Flyer-08-20-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260824
DTEND;VALUE=DATE:20260827
DTSTAMP:20260511T225230Z
CREATED:20260511T225230Z
LAST-MODIFIED:20260511T225230Z
UID:10419-1787529600-1787788799@thebiocalendar.com
SUMMARY:Next Generation Dx Summit
DESCRIPTION:Breakthrough Tech. Expert Insights. Real-World Impact. \n\n400+ diagnostics professionals from across the industry\n120+ speakers leading innovation in clinical and molecular Dx\n6 highly focused tracks spanning emerging technologies and commercial strategy\nUnmatched networking with partners\, labs\, regulators\, and investors\nEmerging company spotlight with novel platform technologies\n\nNext Generation Dx Summit is where the diagnostics ecosystem converges to accelerate innovation and expand patient access \n\n\n\n\nGain the latest insights in: \n\nClinical implementation and validation of diagnostic technologies\nPoint-of-care innovation and at-home testing\nEarly detection and enhanced screening of single cancers and MCEDs\nAI\, digital\, and emerging applications in companion diagnostics\nAI in lab management\, testing\, clinical decision support\, and analysis
URL:https://thebiocalendar.com/event/next-generation-dx-summit-3/
LOCATION:Washington\, DC\, Washington\, DC\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260826T110000
DTEND;TZID=America/Los_Angeles:20260826T120000
DTSTAMP:20260725T054932Z
CREATED:20260720T125405Z
LAST-MODIFIED:20260725T054932Z
UID:10801-1787742000-1787745600@thebiocalendar.com
SUMMARY:Controlling UF/DF with Confidence: How to Define\, Monitor\, and Hit Critical Endpoints
DESCRIPTION:A practical framework for reducing variability\, minimizing manual sampling\, and improving run-to-run consistency with modern UF/DF control strategies. \nAugust 26\, 2026 | 11:00 AM ET \nUltrafiltration Diafiltration (UF/DF) is often treated as a straightforward concentration and buffer-exchange step\, but teams know the reality looks different. Small differences in setup\, endpoint definition\, and in-process decision-making can create major run-to-run variability\, especially as programs move from process development into scale-up and manufacturing. \nIn this webinar\, we will focus on the practical question that determines whether UF/DF is repeatable and scalable: How do you define the right endpoints\, monitor them in real time\, and consistently hit them without relying on constant manual sampling and operator intervention? We will walk through a clear approach to selecting critical UF/DF endpoints (for concentration and diafiltration)\, connecting them to the right measurements\, and using in-line analytics to improve accuracy and consistency. \nKey topics include:\nWhat “critical endpoints” really mean in UF/DF\, and why unclear endpoints drive variability across runs and teams\nEndpoint selection made practical: choosing concentration and diafiltration endpoints that align with process goals and downstream requirements\nHow real-time\, in-line concentration data enables automated control\, reducing manual sampling and dilution while improving efficiency\, consistency\, and decision-making\nReducing variability across scales by linking endpoint definition\, monitoring strategy\, and execution consistency from PD through manufacturing\nTroubleshooting through the lens of control: how clearer endpoints and better monitoring help teams respond faster to instability and performance drift \nWhether you are building a UF/DF strategy in development\, preparing for tech transfer\, or tightening control in manufacturing\, this session will provide practical guidance for making UF/DF easier to run\, easier to scale\, and easier to reproduce.
URL:https://thebiocalendar.com/event/controlling-uf-df-with-confidence-how-to-define-monitor-and-hit-critical-endpoints/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-26-26-Repligen-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260831
DTEND;VALUE=DATE:20260901
DTSTAMP:20260504T221917Z
CREATED:20260504T221917Z
LAST-MODIFIED:20260504T221917Z
UID:10339-1788134400-1788220799@thebiocalendar.com
SUMMARY:ESC Congress 2026
DESCRIPTION:Join us and experience transformation through practice\, policy\, responsibility and genuine human connection. \nThis year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot\, enhancing precision\, speed\, and safety in patient care. Discover AI in action\, from diagnosis to delivery\, through hands-on sessions\, live demonstrations\, and immersive learning. \nHere we will explore a diverse range of topics\, uniting all subspecialties to create a space to share breakthrough data and debate new ideas\, before applying innovation to real-world settings. \nThis is where collaboration becomes progress\, and transformation is not just seen\, but felt.
URL:https://thebiocalendar.com/event/esc-congress-2026/
LOCATION:Munich\, Munich\, Bavaria\, Germany
CATEGORIES:Seminar,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260903
DTSTAMP:20260709T104118Z
CREATED:20260709T104118Z
LAST-MODIFIED:20260709T104118Z
UID:10750-1788220800-1788393599@thebiocalendar.com
SUMMARY:Hubs West
DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite.
URL:https://thebiocalendar.com/event/hubs-west/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Networking,Summit
END:VEVENT
END:VCALENDAR